Dulgeroff A J, Hershman J M
Division of Endocrinology and Metabolism W111D, West Los Angeles VA Medical Center, California 90073.
Endocr Rev. 1994 Aug;15(4):500-15. doi: 10.1210/edrv-15-4-500.
While some of the studies with new therapeutic modalities are encouraging, all are in their early experimental phases. It is likely that better understanding of the molecular basis for differentiated thyroid carcinoma will lead to new therapy in the next decade.
虽然一些采用新治疗方式的研究令人鼓舞,但所有研究都处于早期实验阶段。在未来十年,对分化型甲状腺癌分子基础的更深入了解可能会带来新的治疗方法。